Last reviewed · How we verify
NCT05920395
Mechanisms of Electroacupuncture for Functional Dyspepsia Based on "Enterotypes" and Metabolomics
NA trial testing Electro-acupuncture in Functional Dyspepsia in 130 participants. Status unknown.
30 June 2024
Quick facts
| Lead sponsor | Wuhan Central Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 130 |
| Start date | 1 July 2023 |
| Primary completion | 30 June 2024 |
| Estimated completion | 31 December 2024 |
Drugs / interventions tested
- Electro-acupuncture
- Sham electro-acupuncture group
Conditions studied
- Functional Dyspepsia — all drugs for Functional Dyspepsia →
Sponsor
Wuhan Central Hospital
Who can join
Adults 18 to 65, any sex, with Functional Dyspepsia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to explore the clinical efficacy and possible mechanisms of electroacupuncture treatment for functional dyspepsia (FD). The main question it aims to answer are: * Differences in the effects of electroacupuncture and sham electroacupuncture intervention on FD. * Differences in gastrointestinal hormone levels and gut microbiota and their metabolites between healthy individuals and FD patients. Participants receive electroacupuncture and sham electroacupuncture interventions respectively. Before and after the intervention, the clinical symptom score, gastrointestinal symptom evaluation scale, gastrointestinal symptom score questionnaire, and functional dyspepsia quality of life scale of the subjects will be observed. The levels of gastrointestinal hormones MTL, Ghrelin, 5-HT, CCK, PYY, and GLP-1 will be measured, as well as the changes in microbial diversity and SCFAs in their metabolites in feces, A follow-up visit will be conducted one month after the intervention for all participants.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05920395
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Electro-acupuncture
Trials testing the same drug.
- NCT06772935 — Electroacupuncture Treatment of Peripheral Neuropathy After Taxane Chemotherapy for Breast Cancer · NA · recruiting
- NCT06874959 — Evaluation of the Pain Relief Effect of Battlefield Acupuncture on Patients With Chronic Low Back Pain Due to Lumbar Spi · NA · completed
- NCT06868173 — Trigger Point Electroacupuncture Treatment in Patients With Chronic Low Back Pain · NA · completed
- NCT04957134 — Efficacy of Electro-acupuncture for Abdominal Obesity: Study for a Randomized Controlled Trial · NA · completed
- NCT07455409 — Trial to Study Electro-Acupuncture in Subjects With Chemotherapy-Induced Peripheral Neuropathy · NA · completed
Other recruiting trials for Functional Dyspepsia
Currently open trials in the same condition.
- NCT07442734 — Auricular Stimulation for Functional Dyspepsia With Insomnia: Efficacy and Mechanisms · NA · recruiting
- NCT07250308 — Correlation Study of Atrophic Gastritis and Dyspepsia Symptoms · recruiting
- NCT07187492 — Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia · Phase 4 · recruiting
- NCT07182890 — Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia · Phase 4 · recruiting
- NCT07210294 — Press Needle on Body Acupuncture Points and Auricular Acupuncture Points on Functional Dyspepsia · NA · recruiting
Other Wuhan Central Hospital trials
Trials by the same sponsor.
- NCT06235866 — Risk Identification of Long-term Complications · enrolling by invitation
- NCT05507697 — Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy · Phase 1, PHASE2 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05920395 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wuhan Central Hospital
- Last refreshed: 27 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05920395.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing